Larson Financial Group
TLX icon

Larson Financial Group’s Telix Pharmaceuticals TLX Stock Holding History

Larson Financial Group’s Portfolio TLX Stock Details TLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$9.9K Hold
899
– – ﹤0.01% 2512
2026
Q2 		$10.4K Hold
899
– – ﹤0.01% 2389
2026
Q1 		$8.6K Buy
+899
New +$6.85K ﹤0.01% 2336
2025
Q4 		– Sell
-53
Closed -$507 – 3707
2025
Q3 		$507 Buy
+53
New +$649 ﹤0.01% 3100

Other funds holding TLX

Hennion & Walsh Asset Management
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
Raiffeisen Bank International
Raiffeisen Bank International Vienna, Austria $8.69B AUM 38.11% 1-Year Est. Return
Aubrey Capital Management
Aubrey Capital Management Edinburgh, United Kingdom $115M AUM 51.42% 1-Year Est. Return
WoodTrust Financial
WoodTrust Financial Wisconsin Rapids, Wisconsin $825M AUM 20.13% 1-Year Est. Return
Natixis
Natixis Paris, France $28B AUM 27.03% 1-Year Est. Return
Clearstead Advisors
Clearstead Advisors Cleveland, Ohio $10.8B AUM 17.88% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
EverSource Wealth Advisors
EverSource Wealth Advisors Birmingham, Alabama $3.11B AUM 21.48% 1-Year Est. Return
Wilmington Savings Fund Society
Wilmington Savings Fund Society Wilmington, Delaware $4.39B AUM 17.99% 1-Year Est. Return
Aspect Partners
Aspect Partners Fairfax, Virginia $264M AUM 15.76% 1-Year Est. Return

Larson Financial Group's TLX Position: Q3 2026 in Review

Larson Financial Group held its Telix Pharmaceuticals (TLX) position steady in Q3 2026 at 899 shares worth $9.9K. The position accounts for ﹤0.01% of the portfolio, ranked #2512.

Larson Financial Group first reported a position in TLX in Q3 2025 and has held it in 4 quarters since. The position peaked at $10.4K in Q2 2026. 27 funds tracked by Wall St. Rank hold TLX as of Q3 2026.

  • Larson Financial Group held 899 shares of Telix Pharmaceuticals worth $9.9K as of Q3 2026.
  • Larson Financial Group left its Telix Pharmaceuticals share count unchanged in Q3 2026.
  • Telix Pharmaceuticals made up ﹤0.01% of Larson Financial Group's portfolio in Q3 2026, its #2512 holding.
  • Larson Financial Group first reported a position in Telix Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • Larson Financial Group's Telix Pharmaceuticals position peaked at $10.4K in Q2 2026.
  • 27 funds tracked by Wall St. Rank held Telix Pharmaceuticals as of Q3 2026.

Based on Larson Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.